Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06559202
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-10
Brief Title:
Inguinal and Axillary LN Size Distribution
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluation of Inguinal and Axillary Lymph Node Size Distribution for Safe Intralymphatic Injection
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Recently intralymphatic allergen-specific immunotherapy ILIT showed promising treatment outcomes for allergic rhinoconjunctivitis However the normal size distribution of superficial lymph nodes LNs on the trunk that are potential target LNs for ILIT has not been evaluated
The objective of this study is to investigate the distribution of LN size in inguinal and axillary area
The objective of this study is to investigate the distribution of LN size in inguinal and axillary area
Detailed Description:
In this study the long-axis diameters of the largest LNs in the inguinal and axillary areas were retrospectively measured in subjects who underwent chest and abdominopelvic computed tomography on the same day for health screening purposes from September 2022 to November 2022
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None